Packaging and labeling operations are among the highest-risk activities in pharmaceutical manufacturing, as errors can lead to misbranded product reaching patients. GMP regulations require stringent controls to ensure that every package contains the correct product, strength, and label information.
What Are Packaging and Labeling Operations?
Packaging operations include primary packaging (product contact materials such as blister packs, vials, and bottles) and secondary packaging (cartons, leaflets, and shippers). Labeling operations involve applying printed labels with product information, batch number, expiry date, and increasingly, serialization codes for track-and-trace compliance. Line clearance is performed between different packaging runs to ensure no material from the previous batch remains.
Regulatory Framework
21 CFR Part 211.122–211.137 details labeling and packaging control requirements, including receipt, storage, reconciliation, and destruction of labels. EU GMP Chapter 5 (Production) and Chapter 3 (Premises and Equipment) cover packaging operations. The EU Falsified Medicines Directive (2011/62/EU) mandates serialization and tamper-evident packaging for prescription medicines. ISO 15394 and GS1 standards govern barcode and serialization coding.
Key Requirements
Line clearance requires a documented check that all previous batch materials, labels, and product have been removed before a new batch begins — typically verified by two operators and countersigned by Quality Assurance. Label reconciliation accounts for all labels printed, used, damaged, and destroyed, with a 100% reconciliation expected for critical labels. Serialization requires each saleable unit to carry a unique identifier, which is reported to a national or EU hub database.
Practical Implementation
Automated packaging lines use vision systems to verify labels, barcodes, and serial numbers at high speed. Operators conduct manual checks at defined intervals. Reconciliation is performed at the end of each packaging campaign, with any discrepancy investigated before batch release. Serialization systems must be validated for data integrity and connectivity with national databases.
Common Pitfalls
Label mix-ups — where the wrong label is applied to a product — are among the most serious GMP deviations and are a leading cause of recalls. Inadequate line clearance is another frequent issue, particularly in complex packaging halls where multiple lines run simultaneously.
Conclusion
Packaging and labeling require the same rigor as manufacturing operations. Investment in automated inspection technology and robust line clearance procedures is essential to prevent the potentially life-threatening consequences of mislabeled pharmaceutical products.
